Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Injection for Greater Trochanteric Pain Syndrome
NCT00863889Phase 4Withdrawn
- Sponsor
- Emory University
- Start
- Mar 2009
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in trochanteric bursitis, sponsored by Emory University. Planned start Mar 2009; status: withdrawn.
02
Drugs
methylprednisolone
03
Conditions
trochanteric bursitis
Beyond the preview
Go deeper on NCT00863889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863889.